AGC Biologics is a global contract development and manufacturing organization (CDMO) providing development and manufacturing services for protein-based biologics and advanced therapies. The company specializes in biologics, cell and gene therapies, offering services across protein expression, plasmid DNA (pDNA), mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells.
With a global network of facilities, AGC Biologics supports clients through all stages of development and commercialization, leveraging proprietary technologies and platforms such as AGCellerate™, BravoAAV™, and ProntoLVV™. The company is committed to improving patients’ lives by accelerating the delivery of life-changing biopharmaceuticals to market.
